Although the above focuses on the over-expressed SphK1 in the disease state and the therapeutic effect of SphK1 inhibitors, we cannot ignore the protective effect of SphK1 in some diseases based on the therapeutic effect of K6PC-5 on ischemic heart disease and HD. This evidence concerns the gene SPHK1 and Huntington disease.